iShares Global Healthcare ETF
iShares Trust · 1 share class
Fund classification
Classified from what the fund holds · as of 2026 Q2
iShares Global Healthcare ETF is a U.S. equity index ETF that tracks the S&P Global 1200 Health Care Index.
- Asset class
- Equity
- Region
- United States
- Management
- Index (passive)
- Fund type
- ETF
- Features
- Master-feeder
Fund profile
As filed in the prospectus · 2025 Q3
The iShares Global Healthcare ETF (the Fund ) seeks to track the investment results of an index composed of global equities in the healthcare sector.
The fund tracks the S&P Global 1200 Health Care Index, which comprises large-capitalization healthcare companies across 14 developed markets, using representative sampling to hold a portfolio with similar investment characteristics to the index. Because the fund may not hold all index constituents, its returns may diverge from the index. The fund will concentrate its holdings in healthcare industries to the same extent as the index.
| Share class | Expense ratio |
|---|---|
| IXJ | 0.40% |
Portfolio turnover 5.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.57% |
| Cash & short-term | 1.26% |
| Other | 0.04% |
| Derivatives | 0.02% |
Derivatives are shown at market value, not notional exposure.
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Health Care | 72.8% |
| International | 25.9% |
| Cash | 1.3% |
| Other | 0.0% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Latest quarter
What changed since the fund's previous filing
New: VEEV, XAV HEALTH CARE SEP26, HOLOGIC INC CVR
Exited: HOLOGIC, INC., Pro Medicus Ltd, M3, Inc., SYSMEX CORPORATION, Zealand Pharma A/S, XAV HEALTH CARE JUN26
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| LLY | ELI LILLY AND COMPANYLLY | 10.93% | $1,199.43 | $420.26M | 350.4K |
| JNJ | JOHNSON & JOHNSONJNJ | 7.04% | $253.97 | $270.79M | 1.1M |
| ABBV | ABBVIE INC.ABBV | 5.12% | $251.64 | $196.92M | 782.6K |
| UNH | UNITEDHEALTH GROUP INCORPORATEDUNH | 4.39% | $415.63 | $169.00M | 406.6K |
| MRK | MERCK & CO., INC.MRK | 4.12% | $128.50 | $158.40M | 1.2M |
| — | ASTRAZENECA PLC | 3.76% | $186.70 | $144.53M | 774.1K |
| — | Roche Holding AG | 3.75% | $411.09 | $144.15M | 350.7K |
| — | Novartis AG | 3.71% | $156.29 | $142.81M | 913.8K |
| AMGN | AMGEN INC.AMGN | 2.54% | $362.12 | $97.55M | 269.4K |
| TMO | THERMO FISHER SCIENTIFIC INCORPORATEDTMO | 2.42% | $501.36 | $92.98M | 185.5K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 47.79% of net assets, top 25 71.46%, across 123 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free